CellTolerance

[CellTolerance @CellTolerance]

@CellTolerance H1 2026 Highlights: accelerating global growth!

- Revenue up +145% to €0.9M
- +261% growth across EMEA & ROW
- Rapid expansion across U.S. & key global markets

https://t.co/BbXIIZ144t

#GITwitter

[CellTolerance @CellTolerance]

Standard diagnostics often fail #IBS patients. The @CellTolerance test offers a more clinical approach to relief. Bridge the gap between testing & patient relief at one of these workshops with @RKiesslich & Detlef Schuppan.

Reserve your spot: https://t.co/nsk19abRLT

#GITwitter

[CellTolerance @CellTolerance]

Beyond the 'FODMAP' paradigm: Understanding how specific food intolerances can trigger systemic inflammation and GI distress, often indistinguishable from IBS. The #CellTolerance test helps you identify these triggers with accuracy.

https://t.co/iEmgJmIAxn

#GutHealth #GITwitter

[CellTolerance @CellTolerance]

Thank you to all who joined our @CellTolerance workshop in Bamberg! We showcased how #CellTolerance Test, powered by #Cellvizio, delivers real-time insights into intestinal barrier function, advancing precise, evidence-based care for #foodintolerance and #GI patients. #GITwitter

[CellTolerance @CellTolerance]

The @CellTolerance test can have a profound impact on a patient’s life. Dr. med. Kai Wiemer illustrates how one patient dropped an unnecessary diet, while another uncovered a hidden soy intolerance. Adopt a new approach to #foodintolerance mgmt: https://t.co/ieRMS8OJsy
#GITwitter

[CellTolerance @CellTolerance]

@CellTolerance continues to expand. Univerzitná nemocnica Martin in Slovakia joins the multiple centers worldwide performing this examination routinely, bringing precision gut diagnostics to patients navigating food-triggered symptoms.

@imedex_cz
#foodintolerance #GITwitter

[CellTolerance @CellTolerance]

Standard diagnostics often fail #IBS patients. The @CellTolerance test offers a more clinical approach to relief. Bridge the gap between testing & patient relief at an exclusive workshop with Prof. Jost Langhorst, MD.
Reserve your spot: https://t.co/3DWyzC2883

#GITwitter

[CellTolerance @CellTolerance]

On #WDHD2026, established by @WorldGastroOrg, we're emphasizing @CellTolerance 's vital role in #IBS management. Millions are affected by persistent food-related digestive issues & are looking for a new approach to reclaiming their #digestivehealth.

https://t.co/2DdRFpBgXB

[CellTolerance @CellTolerance]

#ICYMI @CellTolerance is officially expanding into the United Arab Emirates & Turkey! With #IBS & food intolerances impacting up to 27% of the population in these markets, our precision diagnostics are ready to make a major impact.
https://t.co/qR2yS9Njmu

#GITwitter #Cellvizio

[CellTolerance @CellTolerance]

@CellTolerance is coming to the Middle East! Following regulatory clearances in the UAE and Turkey, we confirm our first commercial installation in a region where #IBS & #foodintolerances affect up to 27% of the population on average.
https://t.co/6gM3s798Ga
#Cellvizio #GITwitter

[CellTolerance @CellTolerance]

Inspired by a memorable patient story, Dr. Monica Rusticeanu reflects on the impact of the @CellTolerance test, stating it made her "think openly about a lot of possibilities."

Discover how it’s advancing #IBS patient care: https://t.co/nT5zI8Q84O

#GITwitter

[CellTolerance @CellTolerance]

Did you know? A staggering 1 in 3 IBS patients (33%) feel completely or somewhat out of control of their symptoms. Optimize #IBS patient care by integrating the @CellTolerance program to improve the mgmt & comprehension of IBS in your practice.
https://t.co/Jg0gUkWuQT
#GITwitter

[CellTolerance @CellTolerance]

New #DDW2026 data marks a pivotal moment for patients struggling w/ unexplained gut issues. @CellTolerance + CLE (#Cellvizio) gives physicians real-time, cellular-level visualization of the intestinal mucosa that conventional tests often miss.
https://t.co/tVvRha1nAg
#GITwitter

[CellTolerance @CellTolerance]

Thank you to all physicians who joined us at the @CellTolerance dinner at DDW! Great discussions, compelling data, & experts aligned on addressing this huge patient population. Big thanks to @LindaNguyenMD & @SeanSpencer for their insights. The future of #CellTolerance is here!

[CellTolerance @CellTolerance]

@CellTolerance is transforming #IBS patient care. See the latest abstracts on the new standard of #digestivehealth at #DDW2026 in Chicago!

@DDWMeeting
#CellTolerance #GutHealth #GITwitter #FoodIntolerance

[Cellvizio® by Mauna Kea Technologies @maunakeatech]

Major clinical momentum for #Cellvizio at #DDW2026! 10 new abstracts spanning #pancreaticcysts, IBD assessment, gastric disease, and #foodintolerance,

Read more: https://t.co/w5O52EhQlA

@DDWMeeting @CellTolerance
#GITwitter

[CellTolerance @CellTolerance]

#ICYMI: #CellTolerance is live at @Clinica_Teknon! Huge thanks to Dr. Gherzon Casanova Rimer & team. #CellTolerance powered by #Cellvizio, helps physicians identify food triggers for personalized #IBS care. Global adoption is growing: patients deserve precise answers!
#GITwitter

[Direct Dirigeants @DirectDirigeant]

🎙️ 3 Questions à Sacha Loiseau (Mauna Kea Technologies)

@sachaloiseau, Président Directeur Général de @maunakeatech, revient sur le renouveau de la société, les raisons de l'excellente dynamique commerciale aux U.S. et les bonnes performances de Cell Tolerance.

[CellTolerance @CellTolerance]

Standard diagnostics often fail #IBS patients. The @CellTolerance test offers a more clinical approach to relief. Bridge the gap between testing & patient relief at an exclusive workshop with Prof. Jost Langhorst, MD.

Reserve your spot: https://t.co/uWxKKwqt5L

#GITwitter

[CellTolerance @CellTolerance]

Many IBS-related #foodintolerance tests miss the real cause, often leading to ongoing symptoms & frustration. @CellTolerance can help relieve #IBS symptoms through a proven, multi-disciplinary approach with fast results. https://t.co/gFIuZ5EntT

#IBSAwarenessMonth #GITwitter